Theravance, Inc. (NASDAQ: THRX) announced today that the U.S. FDA has accepted for filing the New Drug Application for telavancin ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE